UROGENITAL CANCER
Clinical trials for UROGENITAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL CANCER trials appear
Sign up with your email to follow new studies for UROGENITAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double-Punch combo trial aims to rev up immune system against tough cancers
Disease control Recruiting nowThis early-stage study is testing whether two new immunotherapy drugs, M7824 and PDS01ADC, can help the body's immune system fight advanced bladder, kidney, and related cancers that have spread. Researchers want to see if adding a precise, high-dose radiation treatment (SBRT) mak…
Matched conditions: UROGENITAL CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Immune-Boosting drug trial aims to improve cancer surgery outcomes
Disease control Recruiting nowThis study is testing if a drug called atezolizumab can shrink tumors before surgery for patients with certain cancers of the urinary system (bladder, kidney, or ureter). The drug works by helping the patient's own immune system recognize and attack the cancer cells. Eligible pat…
Matched conditions: UROGENITAL CANCER
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Landmark study hunts clues in rare urinary cancers
Knowledge-focused Recruiting nowThis study aims to understand the course of rare cancers in the urinary system (like bladder, kidney, and prostate cancers) by tracking patients over time. Researchers will collect medical information, blood, urine, and sometimes tumor samples from about 1,100 adults with these c…
Matched conditions: UROGENITAL CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC